Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

FDA's Approach to Regulating Biosimilars.

Lemery SJ, Ricci MS, Keegan P, McKee AE, Pazdur R.

Clin Cancer Res. 2017 Apr 15;23(8):1882-1885. doi: 10.1158/1078-0432.CCR-16-1354. Epub 2016 Dec 29.

2.

Comparison of Acid Titration, Conductivity, Flame Photometry, ICP-MS, and Accelerated Lamellae Formation Techniques in Determining Glass Vial Quality.

Fujimori K, Lee H, Sloey C, Ricci MS, Wen ZQ, Phillips J, Nashed-Samuel Y.

PDA J Pharm Sci Technol. 2016 May-Jun;70(3):248-55. doi: 10.5731/pdajpst.2015.006056. Epub 2016 Apr 18.

PMID:
27091889
3.

Choice of Starting Dose for Biopharmaceuticals in First-in-Human Phase I Cancer Clinical Trials.

Hansen AR, Cook N, Ricci MS, Razak A, Le Tourneau C, McKeever K, Roskos L, Dixit R, Siu LL, Hinrichs MJ.

Oncologist. 2015 Jun;20(6):653-9. doi: 10.1634/theoncologist.2015-0008. Epub 2015 May 11.

4.

FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma.

Lee HZ, Kwitkowski VE, Del Valle PL, Ricci MS, Saber H, Habtemariam BA, Bullock J, Bloomquist E, Li Shen Y, Chen XH, Brown J, Mehrotra N, Dorff S, Charlab R, Kane RC, Kaminskas E, Justice R, Farrell AT, Pazdur R.

Clin Cancer Res. 2015 Jun 15;21(12):2666-70. doi: 10.1158/1078-0432.CCR-14-3119. Epub 2015 Mar 23.

5.

In-use physicochemical and microbiological stability of biological parenteral products.

Ricci MS, Frazier M, Moore J, Cromwell M, Galush WJ, Patel AR, Adler M, Altenburger U, Grauschopf U, Goldbach P, Fast JL, Krämer I, Mahler HC.

Am J Health Syst Pharm. 2015 Mar 1;72(5):396-407. doi: 10.2146/ajhp140098. No abstract available.

PMID:
25694415
6.

Do not drop: mechanical shock in vials causes cavitation, protein aggregation, and particle formation.

Randolph TW, Schiltz E, Sederstrom D, Steinmann D, Mozziconacci O, Schöneich C, Freund E, Ricci MS, Carpenter JF, Lengsfeld CS.

J Pharm Sci. 2015 Feb;104(2):602-11. doi: 10.1002/jps.24259. Epub 2014 Nov 21.

7.

Revised Gleason grading system is a better predictor of indolent prostate cancer at the time of diagnosis: retrospective clinical-pathological study on matched biopsy and radical prostatectomy specimens.

Giunchi F, Brunocilla E, Borghesi M, Rizzi S, Ricci MS, Romagnoli D, Martorana G, Schiavina R, Fiorentino M.

Clin Genitourin Cancer. 2014 Oct;12(5):325-9. doi: 10.1016/j.clgc.2014.01.009. Epub 2014 Feb 4.

PMID:
24583160
8.

A case study of nondelamination glass dissolution resulting in visible particles: implications for neutral pH formulations.

Ratnaswamy G, Hair A, Li G, Thirumangalathu R, Nashed-Samuel Y, Brych L, Dharmavaram V, Wen ZQ, Fujimori K, Jing W, Sethuraman A, Swift R, Ricci MS, Piedmonte DM.

J Pharm Sci. 2014 Apr;103(4):1104-14. doi: 10.1002/jps.23871. Epub 2014 Feb 4.

PMID:
24496956
9.

Rational design of lyophilized high concentration protein formulations-mitigating the challenge of slow reconstitution with multidisciplinary strategies.

Cao W, Krishnan S, Ricci MS, Shih LY, Liu D, Gu JH, Jameel F.

Eur J Pharm Biopharm. 2013 Oct;85(2):287-93. doi: 10.1016/j.ejpb.2013.05.001. Epub 2013 May 20.

PMID:
23702275
10.

Elucidation of degradants in acidic peak of cation exchange chromatography in an IgG1 monoclonal antibody formed on long-term storage in a liquid formulation.

Gandhi S, Ren D, Xiao G, Bondarenko P, Sloey C, Ricci MS, Krishnan S.

Pharm Res. 2012 Jan;29(1):209-24. doi: 10.1007/s11095-011-0536-0. Epub 2011 Aug 16.

PMID:
21845507
11.

Dysregulated ΔNp63α inhibits expression of Ink4a/arf, blocks senescence, and promotes malignant conversion of keratinocytes.

Ha L, Ponnamperuma RM, Jay S, Ricci MS, Weinberg WC.

PLoS One. 2011;6(7):e21877. doi: 10.1371/journal.pone.0021877. Epub 2011 Jul 15.

12.

A molecular mechanism of hydrolysis of peptide bonds at neutral pH using a model compound.

Pan B, Ricci MS, Trout BL.

J Phys Chem B. 2011 May 19;115(19):5958-70. doi: 10.1021/jp1076802. Epub 2011 Apr 19.

PMID:
21504152
13.

Molecular mechanism of acid-catalyzed hydrolysis of peptide bonds using a model compound.

Pan B, Ricci MS, Trout BL.

J Phys Chem B. 2010 Apr 8;114(13):4389-99. doi: 10.1021/jp905411n.

PMID:
20297769
14.

Regulatory aspects of oncology drug safety evaluation: past practice, current issues, and the challenge of new drugs.

Rosenfeldt H, Kropp T, Benson K, Ricci MS, McGuinn WD, Verbois SL.

Toxicol Appl Pharmacol. 2010 Mar 1;243(2):125-33. doi: 10.1016/j.taap.2009.12.020. Epub 2010 Jan 4. Review.

PMID:
20045015
15.

Silicone oil- and agitation-induced aggregation of a monoclonal antibody in aqueous solution.

Thirumangalathu R, Krishnan S, Ricci MS, Brems DN, Randolph TW, Carpenter JF.

J Pharm Sci. 2009 Sep;98(9):3167-81. doi: 10.1002/jps.21719.

16.

Conformational implications of an inversed pH-dependent antibody aggregation.

Perico N, Purtell J, Dillon TM, Ricci MS.

J Pharm Sci. 2009 Sep;98(9):3031-42. doi: 10.1002/jps.21539.

PMID:
18803243
17.

Mcl-1: a gateway to TRAIL sensitization.

Kim SH, Ricci MS, El-Deiry WS.

Cancer Res. 2008 Apr 1;68(7):2062-4. doi: 10.1158/0008-5472.CAN-07-6278. Review.

18.

Structural and functional characterization of disulfide isoforms of the human IgG2 subclass.

Dillon TM, Ricci MS, Vezina C, Flynn GC, Liu YD, Rehder DS, Plant M, Henkle B, Li Y, Deechongkit S, Varnum B, Wypych J, Balland A, Bondarenko PV.

J Biol Chem. 2008 Jun 6;283(23):16206-15. doi: 10.1074/jbc.M709988200. Epub 2008 Mar 12.

19.

Human IgG2 antibodies display disulfide-mediated structural isoforms.

Wypych J, Li M, Guo A, Zhang Z, Martinez T, Allen MJ, Fodor S, Kelner DN, Flynn GC, Liu YD, Bondarenko PV, Ricci MS, Dillon TM, Balland A.

J Biol Chem. 2008 Jun 6;283(23):16194-205. doi: 10.1074/jbc.M709987200. Epub 2008 Mar 13.

20.

Heritability of the ambulatory arterial stiffness index in Swedish families.

Fava C, Ricci MS, Burri P, Minuz P, Melander O.

J Hum Hypertens. 2008 Apr;22(4):298-300. doi: 10.1038/sj.jhh.1002323. Epub 2008 Jan 3. No abstract available.

PMID:
18172450
21.

Chemotherapy-resistant side-population of colon cancer cells has a higher sensitivity to TRAIL than the non-SP, a higher expression of c-Myc and TRAIL-receptor DR4.

Sussman RT, Ricci MS, Hart LS, Sun SY, El-Deiry WS.

Cancer Biol Ther. 2007 Sep;6(9):1490-5. Epub 2007 Aug 17.

PMID:
17881904
22.

Reduction of TRAIL-induced Mcl-1 and cIAP2 by c-Myc or sorafenib sensitizes resistant human cancer cells to TRAIL-induced death.

Ricci MS, Kim SH, Ogi K, Plastaras JP, Ling J, Wang W, Jin Z, Liu YY, Dicker DT, Chiao PJ, Flaherty KT, Smith CD, El-Deiry WS.

Cancer Cell. 2007 Jul;12(1):66-80.

23.

[Susceptibility of six Arabic coffee cultivars to fruit flies (Diptera: Tephritoidea) under shaded and unshaded organic management in Valença, State of Rio de Janeiro, Brazil].

Aguiar-Menezes EL, Souza SA, Santos CM, Resende AL, Strikis PC, Costa JR, Ricci MS.

Neotrop Entomol. 2007 Mar-Apr;36(2):268-73. Portuguese.

PMID:
17607461
24.

Comparative oxidation studies of methionine residues reflect a structural effect on chemical kinetics in rhG-CSF.

Pan B, Abel J, Ricci MS, Brems DN, Wang DI, Trout BL.

Biochemistry. 2006 Dec 26;45(51):15430-43.

PMID:
17176065
25.

Chemotherapeutic approaches for targeting cell death pathways.

Ricci MS, Zong WX.

Oncologist. 2006 Apr;11(4):342-57. Review.

26.

Optimization of a reversed-phase high-performance liquid chromatography/mass spectrometry method for characterizing recombinant antibody heterogeneity and stability.

Dillon TM, Bondarenko PV, Rehder DS, Pipes GD, Kleemann GR, Ricci MS.

J Chromatogr A. 2006 Jul 7;1120(1-2):112-20. Epub 2006 Jan 30.

PMID:
16448656
27.

Mxi1 is induced by hypoxia in a HIF-1-dependent manner and protects cells from c-Myc-induced apoptosis.

Corn PG, Ricci MS, Scata KA, Arsham AM, Simon MC, Dicker DT, El-Deiry WS.

Cancer Biol Ther. 2005 Nov;4(11):1285-94. Epub 2005 Nov 7.

PMID:
16319523
28.

Modulation of TRAIL-induced tumor cell apoptosis in a hypoxic environment.

Mayes PA, Campbell L, Ricci MS, Plastaras JP, Dicker DT, El-Deiry WS.

Cancer Biol Ther. 2005 Oct;4(10):1068-74. Epub 2005 Oct 18.

PMID:
16294025
29.

Quantitative methods for developing Fc mutants with extended half-lives.

Kamei DT, Lao BJ, Ricci MS, Deshpande R, Xu H, Tidor B, Lauffenburger DA.

Biotechnol Bioeng. 2005 Dec 20;92(6):748-60.

PMID:
16136591
30.

Effects of excipients on the hydrogen peroxide-induced oxidation of methionine residues in granulocyte colony-stimulating factor.

Yin J, Chu JW, Ricci MS, Brems DN, Wang DI, Trout BL.

Pharm Res. 2005 Jan;22(1):141-7.

PMID:
15771240
32.
33.

A comprehensive picture of non-site specific oxidation of methionine residues by peroxides in protein pharmaceuticals.

Chu JW, Yin J, Brooks BR, Wang DI, Ricci MS, Brems DN, Trout BL.

J Pharm Sci. 2004 Dec;93(12):3096-102.

PMID:
15514984
34.

Direct repression of FLIP expression by c-myc is a major determinant of TRAIL sensitivity.

Ricci MS, Jin Z, Dews M, Yu D, Thomas-Tikhonenko A, Dicker DT, El-Deiry WS.

Mol Cell Biol. 2004 Oct;24(19):8541-55.

35.

DNA footprinting.

Ricci MS, El-Deiry WS.

Methods Mol Biol. 2003;223:117-27. No abstract available.

PMID:
12777724
36.

pH Dependence of structural stability of interleukin-2 and granulocyte colony-stimulating factor.

Ricci MS, Sarkar CA, Fallon EM, Lauffenburger DA, Brems DN.

Protein Sci. 2003 May;12(5):1030-8.

37.

Novel strategies for therapeutic design in molecular oncology using gene expression profiles.

Ricci MS, el-Deiry WS.

Curr Opin Mol Ther. 2000 Dec;2(6):682-90. Review.

PMID:
11249746
38.

Bax is a transcriptional target and mediator of c-myc-induced apoptosis.

Mitchell KO, Ricci MS, Miyashita T, Dicker DT, Jin Z, Reed JC, El-Deiry WS.

Cancer Res. 2000 Nov 15;60(22):6318-25.

39.

ECC-1 human endometrial cells as a model system to study dioxin disruption of steroid hormone function.

Ricci MS, Toscano DG, Toscano WA Jr.

In Vitro Cell Dev Biol Anim. 1999 Apr;35(4):183-9.

PMID:
10478797
40.

Estrogen receptor reduces CYP1A1 induction in cultured human endometrial cells.

Ricci MS, Toscano DG, Mattingly CJ, Toscano WA Jr.

J Biol Chem. 1999 Feb 5;274(6):3430-8.

41.

Aloneness in tenuous self-states.

Ricci MS.

Perspect Psychiatr Care. 1991;27(2):7-11.

PMID:
1788045
42.

The new after-care clinic: treating individuals rather than masses.

Ricci MS.

J Psychosoc Nurs Ment Health Serv. 1990 Aug;28(8):18-21. No abstract available.

PMID:
2168946
43.

[Preliminary considerations on blood lipid parameters and blood insulin after oral glucose tolerance test].

Ricci MS, Castaldi D, Samueli R, Boghich O.

Quad Sclavo Diagn. 1986 Mar;22(1):58-67. Italian.

PMID:
3538125
44.

An experiment with personal-space invasion in the nurse-patient relationship and its effect on anxiety.

Ricci MS.

Issues Ment Health Nurs. 1981 Jul-Sep;3(3):203-18. No abstract available.

PMID:
6913553

Supplemental Content

Loading ...
Support Center